294. Congenital diaphragmatic hernia Clinical trials / Disease details
Clinical trials : 16 / Drugs : 26 - (DrugBank : 5) / Drug target genes : 5 - Drug target pathways : 14
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2013-002026-22-NL (EUCTR) | 24/10/2013 | 27/06/2013 | Adminstration of omeprazole by rectiole or oral tablet for the treatment of reflux disease in neonates and infants with a closure of the esophagus or a congenital opening in the diaphragm. | Rectal and oral omeprazole treatment of gastroesophageal reflux in infants with esophageal atresia or congenital diaphragmatic hernia.A pharmacodynamic and pharmacokinetic study - NEOPREMEC | GORD,;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] | Trade Name: Losec Product Name: Omeprazol Product Code: NA Trade Name: Losec Product Name: Omeprazol Product Code: NA | ErasmusMC | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Netherlands | ||||
| 2 | NCT00226044 (ClinicalTrials.gov) | September 2005 | 22/9/2005 | Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants. | Rectal and Oral Omeprazole Treatment of Gastroesophageal Reflux in Infants With Esophageal Atresia or Congenital Diaphragmatic Hernia; A Pharmacodynamic and Pharmacokinetic Study. | Gastroesophageal Reflux;Esophageal Atresia;Hernia, Diaphragmatic | Drug: Omeprazole rectally 1mg/kg | Rijnstate Hospital | Erasmus Medical Center | Completed | 6 Weeks | 3 Months | All | 17 | Phase 3 | Netherlands |